News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
Sleep-Aligned Fasting May Support Overnight Heart Health
July 9, 2026 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
Researchers found that aligning fasting with the body’s natural sleep cycle before bedtime may support cardiovascular and metabolic health.
Read Article
AMP® BGTC Announces FDA Clearance of Investigational New Drug Application for Gene Therapy Targeting Multiple Sulfatase Deficiency
July 6, 2026 - Grantee/Partner News
- Bespoke Gene Therapy Consortium (BGTC)
The FDA cleared the Investigational New Drug (IND) application for a gene therapy designed to treat children with multiple sulfatase deficiency (MSD), an ultra-rare disease.
Read ArticleScience Update: Blood Transfusions for Preterm Infants Not Associated With Risk for Necrotizing Enterocolitis, NIH-Funded Study Suggests
May 22, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Black Americans: A Link Between Cognitive Health and Financial Instability
May 22, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Addressing Disparities in Alzheimer’s Disease Through Culturally Tailored Health Information
May 22, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Science Update: Cerebral Palsy Increased Among Extremely Preterm Infants From 2008 to 2019, NIH-Funded Study Suggests
May 21, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Center for Experimental Therapeutics Translates Lab Discoveries to Treatments
May 21, 2024 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Paving the Way for Ultrarare Bone Disease Treatment Trial
May 21, 2024 - NCATS News
- Our Impact on Drug Discovery and Development
- Therapeutics for Rare and Neglected Diseases (TRND)
Clinicians at the NIH Clinical Center will soon start testing an investigative drug for an ultrarare bone disease. Efforts from NCATS’ scientists helped make this research milestone possible.